Combination of [¹⁷⁷Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model

Peptide receptor radionuclide therapy (PRRT) relies on α- and β-emitting radionuclides bound to a peptide that commonly targets somatostatin receptors (SSTRs) for the localized killing of tumors through ionizing radiation. A Lutetium-177 (¹⁷⁷Lu)-based probe linked to the somatostatin anal...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Marina Simón, Jesper Tranekjær Jørgensen, Harshvardhan A. Khare, Camilla Christensen, Carsten Haagen Nielsen, Andreas Kjaer
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2022-06-01
Cyfres:	Pharmaceutics
Pynciau:	photothermal therapy (PTT) nanoshells (NS) peptide receptor radionuclide therapy (PRRT) [<sup>177</sup>Lu]Lu-DOTA-TATE somatostatin receptor (SSTR) cancer
Mynediad Ar-lein:	https://www.mdpi.com/1999-4923/14/6/1284
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!